January 30, 2001
Phyne Pharmaceuticals Is Not Recalling Adrenal Cortex Extract;
Product Remains A Concern To FDA
DC (SafetyAlerts) - Phyne Pharmaceuticals
Inc. has informed FDA that it is not recalling vials of injectable Adrenal Cortex Extract
(ACE) manufactured by AMRAM Inc. FDA had included ACE in its January 25, 2001 press release about the Phyne Pharmaceuticals recall.
FDA shares the same safety concern about ACE as it does with the products which Phyne
Pharmaceuticals is recalling because all of the products were manufactured by AMRAM Inc.
under the same conditions violating good manufacturing standards for pharmaceuticals.
Vials of ACE manufactured by AMRAM Inc. will bear AMRAMs name on the label.
FDA strongly recommends this product not be used, and it be disposed of by being destroyed
in such a manner rendering it unusable.
Safety Alerts compiles comprehensive safety recall information for
the United States. SafetyAlerts Newsletter is a free
email service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.